FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:355 August 1, 1996 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Vaccination with hepatitis B recombinant vaccine has few serious side effects¹ (about 1 per 100,000 doses administered). Some cases of vasculitis have been reported.² We report two cases of vasculitis with cryoglobulinemia after vaccination against hepatitis B.

A previously healthy, 18-year-old woman who was not taking any medication on a regular basis received a first dose of hepatitis B recombinant vaccine (GenHevac, Pasteur Vaccines) in March 1995 and a second dose in April 1995. Ten days after she received the second dose, painful necrotic and bullous purpura of the legs, suggestive of cutaneous vasculitis, developed. The lesion . . . [Full Text of this Article]

References

This article has been cited by other articles:

• VANOLI, M., GAMBINI, D., SCORZA, R. (1998). A case of Churg-Strauss vasculitis after hepatitis B vaccination. Ann Rheum Dis 57: 256-257 [Full Text]